Update on PALLAS, an International Academic Breast Cancer Study Evaluating Adjuvant Palbociclib
Second Interim Analysis of Adjuvant Study for HR+, HER2- Early Breast Cancer demonstrates that there is little chance of palbociclib reducing the risk of recurrence.
Real-World Prevalence of PD-L1 Expression Among Tumor Samples From Patients With Non-Small-Cell Lung Cancer
Ana C Z Gelatti, Vladmir C Cordeiro de Lima, Helano Freitas, Gustavo Werutsky, Ana Maria Gaiger, Clovis Klock, Patricia P Viola, Christina Shiang, Mariana P de Macedo , Lisandro F Lopes, Pedro De Marchi, Eduardo Caetano Albino da Silva, Fernando Moura, Giuliano Borges, Facundo Zaffaroni, Paulo Ricardo Nunes Filho, Luiz H Araujo, Eldsamira Mascarenhas, Clarissa Mathias, Carlos Barrios, Mauro Zukin PMID:
De-escalation of Neoadjuvant Therapy for HER2-positive Early Breast Cancer: An Overview
Gustavo Werutsky 1, Mahira Lopes Rosa 2 PMID: 32527121 DOI: 10.21037/apm-20-1035 Full link: https://pubmed.ncbi.nlm.nih.gov/32527121/
Advanced Renal Cell Carcinoma (RCC) Management: An Expert Panel Recommendation From the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG)
Andrey Soares, Fernando Sabino Marques Monteiro, Fernando Cotait Maluf, Diogo Assed Bastos, Denis Leonardo Jardim, André Deeke Sasse, Adriano Gonçalves E Silva, André P Fay, Diogo Augusto Rodrigues da Rosa, Evanius Wierman, Fabio Kater, Fabio A Schutz, Fernando Nunes Galvão de Oliveira, Igor Alexandre Protzner Morbeck, José Augusto Rinck Jr, Karine Martins da Trindade, Manuel Caitano Maia, Vinicius Carrera Souza,
First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis
Fernando Sabino M Monteiro, Andrey Soares, Márcio Debiasi, Fabio A Schutz, Fernando Cotait Maluf, Diogo Assed Bastos, Andre Sasse, Carolina G S Cauduro, Gabriela Oliveira Mendes, Patricia K Ziegelmann, André P Fay PMID: 32303427 DOI: 10.1016/j.clgc.2020.02.012 Full link: https://pubmed.ncbi.nlm.nih.gov/32410064/